Antibiotics overuse in global protein supply chains

FAIRR’s collaborative investor engagement on antibiotics is supported by more than 70 institutional investors representing nearly $5 trillion in AUM. The engagement asks 20 global food companies to limit antibiotic use in their supply chains to protect public health and long-term value creation by:

1) Establishing an antibiotics policy to phase out routine, prophylactic use across all supply chains.

2) Specifying clear targets and timelines for implementation.

3) Increasing transparency by reporting on implementation and data verification.

Latest progress report

FAIRR’s latest update on this engagement outlines how investors are stepping up to manage these risks and progress made on this issue from the corporate and policy communities.


Antibiotics use in livestock is a leading cause of rising antimicrobial resistance (AMR) in humans. The food industry is the largest consumer of antibiotics globally, and uses antibiotic drugs to prevent disease or promote growth in healthy farm animals rather than treat clinically ill animals.

AMR and antibiotics misuse presents a systemic risk to investor portfolios, including within the food, pharmaceutical, healthcare and insurance industries.

The UK government described the over-use of antibiotics as “excessive and inappropriate” in a report which found that drug-resistant infections could cost the world around US $100 trillion in lost output by 2050 – a cost that will come home to roost in a widely diversified portfolio.

Main contact: Jo Raven, Engagement Manager

Related reports

See the full range of briefings we have released on antibiotics overuse in supply chains.


Outlines investment risks linked to farm antibiotic misuse, and how investors can drive improvements in the food industry.…

14th Nov 2016 | FAIRR_admin


Becoming an investor member of FAIRR puts you at the heart of a global network of investors seeking to understand and manage issues linked to intensive livestock production.

Why join?

  • Access to new research and analysis on the potential material impacts of factory farming.
  • Regular updates, presentations, newsletters and private events.
  • The opportunity to join collaborative engagements with relevant companies (investor members only).
  • Access to best practice tools, networking and knowledge sharing with the FAIRR investor network.
  • Showing a public commitment to considering factory farming issues as part of the investment process.